RESULTS	In the first study , GBE reduced AMS incidence ( 7/21 ) vs placebo ( 13/19 ) ( P = .027 , number needed to treat = 3 ) , and it also reduced severity ( AMS-C = 0.77 + / - 0.26 vs 1.59 + / - 0.27 , P = .029 ) .\